FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
V Vaccaro, I Sperduti, M Milella - The New England journal of …, 2011 - europepmc.org
V Vaccaro, I Sperduti, M Milella
The New England journal of medicine, 2011•europepmc.orgFOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help
Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus
Search life-sciences literature (Over 39 million articles, preprints and more) Search Advanced
search Feedback This website requires cookies, and the limited processing of your personal
data in order to function. By using the site you are agreeing to this as outlined in our privacy …
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help
Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus
Search life-sciences literature (Over 39 million articles, preprints and more) Search Advanced
search Feedback This website requires cookies, and the limited processing of your personal
data in order to function. By using the site you are agreeing to this as outlined in our privacy …
Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study.
europepmc.org